Aslani, Iris .
HRN: 24-25-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
MUPIROCIN 2%, 15G (TUBE)
05/13/2024
05/20/2024
TOPICAL
Pea Sized Amount
3x A Day
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes